Acetazolamide Injection, Powder, Lyophilized, For Solution
Product Images NDC 72078-092

2 FDA label images from Mylan Institutional Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acetazolamide (NDC 72078-092). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Acetazolamide Chemical Structure (Image 01)

Acetazolamide Chemical Structure (Image 01)
Chemical structure diagram of acetazolamide sodium showing its molecular formula C4H6N4O3S2 and molecular weight 222.24.*
FDA Label Image

Acetazolamide For Injection 500 mg Carton Label (Image 02)

Acetazolamide For Injection 500 mg Carton Label (Image 02)
Acetazolamide 500 mg injection, USP powder, lyophilized for intravenous use, in a single vial. The packaging label displays the proprietary name Acetazolamide, strength 500 mg, and indicates the product is sterile and for intravenous use. Manufactured for Mylan Institutional LLC, Morgantown, WV, with a mention of manufacturing in India. The label includes storage instructions, dosage information references, and preservatives information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.